The non-targeted DM1 myoblasts showed a 3% reduction in DMPK mRNA level compared to the non-treated DM1 myoblasts (Figure 3B blue bar vs. orange bar, 2.81 vs. 2.9). This evidence concerns the gene DMPK and myotonic dystrophy type 1.